Serum concentration and cardiovascular effects of salbutamol after oral and rectal administration in healthy volunteers

作者: N. Kurosawa , E. Owada , A. Kato , K. Bando , K. Ito

DOI: 10.1111/J.1365-2710.1993.TB00575.X

关键词:

摘要: SUMMARY In order to evaluate rectal administration of salbutamol (SB), five healthy volunteers were dosed orally and rectally with racemic SB (0–1 mg/kg) solution. Compared the oral SB, gave significantly higher serum concentration immediately after dosing but slightly lower levels in elimination phase. The CBMX following was 17–9 ng/ml (17–0 for administration), tmax 0–67 h (1–5 administration) AUC 98–2 ng/ml/h (100 administration). Heart rate also rose more rapidly a maximum 70% above baseline values dosing. continued be twice larger than up 5 h. versus response curves indicated that effective at increasing heart same serum. A plausible explanation this phenomenon might difference stereo–selective first–pass metabolism two enantiomers. Therefore, dose administered as suppository prophylactic treatment asthma should used orally.

参考文章(15)
E. A. Stemmann, G. E. Wolff, Salbutamol (Aerosol und Zäpfchen) bei Kindern mit Asthma bronchiale Springer Berlin Heidelberg. pp. 89- 92 ,(1980) , 10.1007/978-3-662-38563-0_24
C.J. de Blaey, J. Polderman, Rationales in the Design of Rectal and Vaginal Delivery Forms of Drugs Drug Design. ,vol. 9, pp. 237- 266 ,(1980) , 10.1016/B978-0-12-060309-1.50011-2
Allan H. Price, Stephen P. Clissold, Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs. ,vol. 38, pp. 77- 122 ,(1989) , 10.2165/00003495-198938010-00004
Ewoud J. van Hoogdalem, Albertus G. de Boer, Douwe D. Breimer, Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. Clinical Pharmacokinectics. ,vol. 21, pp. 110- 128 ,(1991) , 10.2165/00003088-199121020-00003
M. Eichelbaum, P. Birkel, E. Grube, U. G�tgemann, A. Somogyi, Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment Journal of Molecular Medicine. ,vol. 58, pp. 919- 925 ,(1980) , 10.1007/BF01477049
Clifford J. Hawkins, Klease Gregory T., Relative potency of (-)- and (+-)-salbutamol on guinea pig tracheal tissue Journal of Medicinal Chemistry. ,vol. 16, pp. 856- 857 ,(1973) , 10.1021/JM00265A026
DJ Morgan, JD Paull, BH Richmond, E Wilson-Evered, SP Ziccone, Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. British Journal of Clinical Pharmacology. ,vol. 22, pp. 587- 593 ,(1986) , 10.1111/J.1365-2125.1986.TB02939.X
SR Smith, C Ryder, MJ Kendall, R Holder, Cardiovascular and biochemical responses to nebulised salbutamol in normal subjects. British Journal of Clinical Pharmacology. ,vol. 18, pp. 641- 644 ,(1984) , 10.1111/J.1365-2125.1984.TB02520.X
R. T. BRITTAIN, J. B. FARMER, R. J. MARSHALL, Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol British Journal of Pharmacology. ,vol. 48, pp. 144- 147 ,(1973) , 10.1111/J.1476-5381.1973.TB08232.X
D. Hartley, D. Middlemiss, Absolute configuration of the optical isomers of salbutamol. Journal of Medicinal Chemistry. ,vol. 14, pp. 995- ,(1971) , 10.1021/JM00291A036